Home LiteratureArticle Details
PMID: 40679298 Published · ppublish English

Two New Families With TAF13 Variant Presenting With Syndromic 46,XY Disorder of Sex Development: Expanding the Clinical Phenotype.

American journal of medical genetics. Part A ·Vol. 197 ·No. 12 ·2025-12-00

Arı H, Türkyılmaz A, Doğan Arı AB, Kardeş H, Sezer A, Cimbek EA, Savaş Erdeve Ş, Karagüzel G

Abstract

Intellectual developmental disorder, autosomal recessive 60 (MRT60, #617432) is an ultrarare genetic disorder characterized by microcephaly, intellectual disability, growth retardation, seizure, and central nervous system abnormalities. The disease is caused by biallelic variants in the TATA box-binding protein-associated factor gene (TAF13) gene. To date, only four patients with MRT60 have been reported in the literature. In this study, two new patients were presented, exhibiting similar phenotypic features including microcephaly, intellectual disability, and prominent growth retardation. Whole exome analysis revealed a pathogenic variant (c.119T>A p.Met40Lys) in the TAF13 gene. The 46,XY disorder of sex development was only present in the current patients and is a new finding for this ultrarare disorder. Since TAF13 plays a role in transcriptional regulation, it is believed to potentially cause gonadal dysfunction. To obtain a better understanding of this disorder, it is essential to conduct comprehensive functional studies that can provide deeper insights into the underlying mechanisms.

Keywords
TAF13 46 XY DSD MRT60 intellectual disability microcephaly whole‐exome sequencing
Article Info
Journal
American journal of medical genetics. Part A
Abbr.
Am J Med Genet A
ISSN
1552-4833
Published
2025-12-00
Language
English
Country/Region
United States
NLM ID
101235741
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com